Maternal and Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy

Author:

Granese Roberta1ORCID,Calagna Gloria2ORCID,Alibrandi Angela3ORCID,Martinelli Canio4,Romeo Paola4,Filomia Roberto5,Ferraro Maria Immacolata6,Piccione Eleonora7,Ercoli Alfredo4,Saitta Carlo5

Affiliation:

1. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University Hospital “G. Martino”, Via Consolare Valeria 1, Gazzi, 98100 Messina, Italy

2. Obstetrics and Gynecology, “Villa Sofia Cervello” Hospital, University of Palermo, Via Trabucco 180, 90127 Palermo, Italy

3. Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, Via dei Verdi, 98166 Messina, Italy

4. Department of Human Pathology in Adulthood and Childhood, University Hospital “G. Martino”, Via Consolare Valeria 1, Gazzi, 98100 Messina, Italy

5. Department of Clinical and Experimental Medicine, University Hospital “G. Martino”, Via Consolare Valeria 1, Gazzi, 98100 Messina, Italy

6. Family Counseling, ASP Messina, Via Catania 14, Sant’Agata di Militello, 98100 Messina, Italy

7. Family Counseling, ASP Messina, Via Trento 8, Brolo, 98100 Messina, Italy

Abstract

The aims of our study were to evaluate the maternal and fetal outcomes of intrahepatic cholestasis of pregnancy (ICP). In this observational, retrospective case–control study, we included all pregnant women who gave birth with a diagnosis of ICP between January 2010 and December 2020 at the Unit of Obstetrics and Gynecology, University Hospital of Messina. The data were compared with those from a control group of pregnant women who did not have ICP. One hundred twenty-nine and eighty-five patients were included, respectively, in the study and in the control group. There was a significant difference between the two groups in the incidence of hypothyroidism, thrombophilia, gestational diabetes, gestational hypertension, postpartum hemorrhage, and preterm delivery, which were more frequent in the ICP patients. No neonatal adverse events were recorded, although a significant difference in the meconium-stained amniotic fluid condition was noted. After a 24-month follow-up, 48/129 patients with ICP accepted to be reassessed by liver ultrasound, elastographic examination, and liver function blood tests. No patient showed signs of chronic liver disease. This study confirmed a higher probability of adverse short-term maternal outcomes in ICP pregnant patients, but a lower probability of adverse short-term fetal outcomes and the absence of a long-term maternal risk of chronic liver disease.

Publisher

MDPI AG

Subject

General Medicine

Reference44 articles.

1. Clinical practice guidlines of team of experts of the polish gynecolical society: Managment of intrahepatic cholestasis of pregnancy;Oleszczuk;Ginekol. Pol.,2012

2. Cholestasis of pregnancy;Lorente;Gastroenterol. Hepatol.,2007

3. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management;Wood;Obstet. Gynecol. Surv.,2018

4. Intrahepatic cholestasis of pregnancy;Williamson;Obstet. Gynecol.,2014

5. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: A 12-year population-based cohort study;Marschall;BJOG,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3